Endocannabinoid immune and vascular signaling

Acta Pharmacologica Sinica

Volumn 21, Issue 12, 2000, Pages 1071-1081

  Stefano, G B ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

2 Arachidonyl glyceral; Anandamide; Cannabinoid receptors; Hemp; Immune cells; Nitric oxide; Vascular endothelium

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; CANNABIS; NITRIC OXIDE;

ARTICLE; CELL ADHESION; HUMAN; INFLAMMATORY CELL; INVERTEBRATE; NONHUMAN; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VERTEBRATE;

AGED; ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; CANNABIS; ENDOCANNABINOIDS; HUMANS; MACROPHAGES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PLANTS, MEDICINAL; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SIGNAL TRANSDUCTION; VASODILATION;

EID: 0034534347     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Conformational matching: A determining force in maintaining signal molecules
2. The effects of delta 9-tetrahydrocannabinol on action potentials in the mollusc Aplysia
3. Action of delta 9-tetrahydrocannabinol on cell division and macromolecular synthesis in division-synchronized protozoa
4. Effect of delta 9-tetrahydrocannabinol on cyclic nucleotides in synchronously dividing Tetrahymena
5. Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction
6. Occurrence and metabolism of anandamide and related acyl-ethanolamides in ovaries of the sea urchin Paracentrotus lividus
7. Inhibition of sea urchin fertilization by fatty acid ethanolamides and cannabinoids
8. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes
9. Presence of the mu3 opiate receptor in endothelial cells: Coupling to nitric oxide production and vasodilation
10. Morphine stimulates nitric oxide release from invertebrate microglia
11. Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide
12. Arachidonyl-glycerol stimulates nitric oxide from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1
13. Bioactive long chain N-acylethanolamines in five species of edible bivalve molluses. Possible implications for mollusc physiology and seafood industry
14. Identification and characterization of the leech CNS cannabinoid receptor: Coupling to nitric oxide release
15. Morphine and anandamide stimulated nitric oxide production inhibits presynaptic dopamine release
16. Opioids inhibit potassium-stimulated dopamine release in the marine mussel Mytilus edulis and in the cephalopod, Octopus bimaculatus
17. Anandamide amidase inhibition enhances anandamide-stimulated nitric oxide release in invertebrate neural tissues
18. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: Possible role in the feeding response
19. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion
20. Cannabis, marijuana and cannabinoid toxicological manifestations in man and animals
21. A cannabinoid with cardiovascular activity but no overt behavioral effects
22. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide
23. The triple effect induced by delta 9-tetrahydrocannabinol on the rat blood pressure
24. Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat
25. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors
26. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats
27. Production and physiological actions of anandamide in the vasculature of the rat kidney
28. Mechanism of the hypotensive action of anandamide in anesthetized rats
29. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
30. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
31. Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: Is 2-arachidonoyl glycerol a possible vasomodulator?
32. Functional CB1 cannabinoid receptors in vascular endothelial cells
33. Anandamide, a naturally occurring agonist of the cannabinoid receptor, blocks adenylate cyclase at the frog neuromuscular junction
34. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
35. G-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs
36. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent
37. Pharmacological evidence for anandamide amidase in human cardiac and vascular tissues
38. Antagonist of LPS and INF-γ induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase
39. An endogenous cannabinoid as endothelium-derived vasorelaxant
40. Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation
41. + current in B cluster neurons of Aplysia by nitric oxide donor
42. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock
43. Cryopreserved veins used for myocardial revascularization: A 5 year experience and a possible mechanism for their increased failure
44. Autoimmunovascular regulation: Morphine and anandamide stimulated nitric oxide release
45. Antagonism of LPS and INF-γ induced iNOS expression in human atrial endothelia by morphine, anandamide and estrogen
46. The cardiovascular actions of cannabinoids
47. Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9 tetrahydrocannabinol
48. Delta-9-tetrahydrocannabinol modulates antigen processing by macrophages
49. Inhibition by delta-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages
50. Inhibition of macrophage inducible protein expression by delta-9-tetrahydrocannabinol
51. delta-9-tetrahydrocannabinol (THC) modulates IL-1 bioactivity in human monocyte/macrophage cell lines
52. Marijuana and immunity: Tetrahydrocannabinol-mediated inhibition of growth and phagocytic acitivity of the murine macrophage cell line, P388D1
53. Suppressive effect of delta-9-tetrahydrocannabinol in vitro on phagocytosis by murine macrophages
54. Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro
55. Suppression of human macrophage function in vitro by delta 9-tetrahydrocannabinol
56. Behavioral effects of opiates on the land snail Helix aspersa
57. Evidence for nitric oxide production and utilization as a bacteriocidal agent by invertebrate immunocytes
58. Molecular characterization of a peripheral receptor for cannabinoids
59. An assessment of the role of opioid receptors in the response to Cannabimimetic drugs
60. Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain
61. Blockade of cannabinoid-induced antinociception by naloxone benzoylhydrazone (NalBZH)
62. Drug addiction and drug abuse
63. Long-term exposure of human blood vessels to HIV gp120, morphine and anandamide increases endothelial adhesion of monocytes: Uncoupling of Nitric Oxide
64. Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: Endothelial implications
65. Effect of prolonged exposure to morphine on responsiveness of human and invertebrate immunocytes to stimulatory molecules
66. Rebound from nitric oxide inhibition triggers enhanced monocyte activation and chemotaxis
67. Estradiol coupling to endothelial nitric oxide production stimulates GnRH release from rat median eminence
68. Estradiol coupling to human monocyte nitric oxide release is dependent on intracellular calcium transients: Evidence for an estrogen surface receptor
69. Basal nitric oxide limits immune, nervous and cardiovascular excitation: Human endothelia express a mu opiate receptor
70. Opioid and opiate immunoregulatory processes
71. Endogenous morphine and related opiates, a new class of chemical messengers
72. Endogenous morphine levels increase following cardiac surgery: Decreasing proinflammatory cytokine levels and immunocyte activity
73. Opiate, cannabinoid, and eicosanoid signaling converges on common intracellular pathways: Nitric oxide coupling
74. Endogenous morphine
75. New role for estrogen in cancer?
76. Substance abuse and HIV-gp120: Are opiates protective?
77. Morphine inhibits NF-κB nuclear binding in human neutrophils and monocytes by a nitric oxide dependent mechanism
78. NF-kB, nitric oxide and opiate signaling
79. The biology of deception: The evolution of cognitive coping as a denial-like process
80. The biology of deception: Emotion and morphine
81. Anandamide-induced conformational changes in leech and mussel immunocytes are mediated by nitric oxide
82. Human aortocoronary grafts and nitric oxide release: Relationship to pulsatile pressure